The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review

BACKGROUND: Checkpoint inhibitor immunotherapy has not proven clinically effective in glioblastoma. This lack of effectiveness may be partially attributable to the frequent administration of dexamethasone in glioblastoma patients. In this systematic review, we assess whether dexamethasone (1) affect...

Descripció completa

Dades bibliogràfiques
Autors principals: Swildens, Kyra X, Sillevis Smitt, Peter A E, van den Bent, Martin J, French, Pim J, Geurts, Marjolein
Format: Online Article Text
Idioma:English
Publicat: Oxford University Press 2022
Matèries:
Meta-Analysis
Accés en línia:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389427/
https://www.ncbi.nlm.nih.gov/pubmed/35990704
http://dx.doi.org/10.1093/noajnl/vdac087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389427/
https://www.ncbi.nlm.nih.gov/pubmed/35990704
http://dx.doi.org/10.1093/noajnl/vdac087

Ítems similars